Hydroxyapatite nanowire ceramic bone bandage and preparation method thereof
By using hydroxyapatite nanowire ceramic bone bandages, the problem of slow bone healing and non-degradable materials in existing orthopedic treatments has been solved, and the effect of good biocompatibility, degradability and accelerated bone healing is achieved. It is suitable for a variety of purposes Orthopedic treatment needs.
Patent Information
- Application Number
- CN202411193593.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-28
- Publication Date
- 2024-11-22
AI Technical Summary
The existing titanium alloy bone plate nails, K-S and intramedullary needles commonly used in orthopedic treatment have problems such as poor biocompatibility, non-degradability, requiring secondary surgery, and stress shielding, resulting in bone healing cycle. The patient is suffering and inconvenient.
Using hydroxyapatite nanowires as substrate, adding bioglass, polymers and fibers, a degradable, flexible, and biocompatible hydroxyapatite nanowire ceramic bone bandage is prepared through 3D printing technology, using its nanostructure and height Specific surface area accelerates bone healing.
It has achieved the acceleration of bone healing, reduced postoperative adverse reactions, avoided secondary surgery, improved the strength and toughness of bone bandages, adapted to the treatment needs of different parts and degrees of injury, and lowered the technical threshold of doctors.
Smart Images

Figure CN118987378A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of medical bioceramics, and in particular to a hydroxyapatite nanowire ceramic bone bandage and a preparation method thereof. Background Art
[0002] Nowadays, the number of orthopedic diseases caused by bone tissue defects caused by trauma, tumors and genetic diseases is increasing. According to research and statistics from relevant departments, about 5% to 10% of fractures cannot heal within a normal time, resulting in a diagnosis of delayed healing, or developing into non-union, and ultimately leading to non-union. These cases require repeated surgical interventions, resulting in an increase in the incidence rate of patients and increased pain for patients.
[0003] Common bone internal fixation instruments include bone plates, bone screws, bone pins, suture nails, etc. Common natural and synthetic degradable and non-degradable biomaterials include allogeneic bone, hydroxyapatite, zirconium oxide, magnesium alloy, tantalum alloy, titanium alloy, etc. In the orthopedic treatment of bone fractures, fractures, osteoporosis, nonunion, etc., non-degradable titanium alloy bone plates, bone screws, stainless steel bone pins, and titanium alloy intramedullary nails have significant differences in structure and composition from natural bone tissue, such as relatively poor biocompatibility and inability to form a strong bond with surrounding bone tissue like natural bone. Solid bonds, etc., can easily cause adverse reactions in the body, such as fibrosis and postoperative inflammation; in addition, non-degradable products require a second operation to remove them after the patient recovers or remain in the patient's body permanently, which brings great inconvenience to the patients; at the same time, the mismatch between the mechanical properties and elastic modulus with natural bones will lead to the phenomenon of stress shielding in which the implant bears most of the stress while the bone tissue is almost unaffected by the stress. Long-term stress shielding can lead to disuse atrophy and osteoporosis of the bone tissue, leading to secondary fractures. These factors have become the key factors limiting its perfect biological integration with the human body.
[0004] To summarize, the bone fixation products currently commonly used in the treatment of orthopedic diseases such as fractures, bone cracks, and nonunion, such as titanium alloy bone plates, bone nails, Kirschner wires, and intramedullary nails, require high surgical skills from doctors and are inconvenient to use. The use of non-degradable or non-completely degradable products requires a secondary surgery after implantation, which increases the patient's pain. They cannot release effective calcium and phosphorus elements to promote bone healing, which prolongs the bone healing cycle. In addition, the usable range of a single product is small, and stress shielding is prone to occur. Summary of the invention
[0005] The purpose of the present invention is to provide a hydroxyapatite nanowire ceramic bone bandage and a preparation method thereof, so as to overcome the problems existing in the prior art. The present invention can use hydroxyapatite nanowires as a matrix, add a certain proportion of bioglass, polymers, fibers and other degradable substances therein, and prepare a viscous slurry that can be used for 3D printing. Subsequently, 3D printing technology and a method for self-assembly of hydroxyapatite nanowires can be used to prepare a flexible hydroxyapatite nanowire bundle for weaving hydroxyapatite nanowire-based ceramic bone bandages with controllable length and diameter. Finally, the flexible hydroxyapatite nanowire bundle can be used to prepare a degradable, easy-to-operate, biocompatible hydroxyapatite nanowire ceramic bone bandage that can accelerate bone healing by weaving.
[0006] In order to achieve the above object, the technical solution adopted by the present invention is as follows: A method for preparing a hydroxyapatite nanowire ceramic bone bandage comprises the following steps: (1) Stirring deionized water with a magnetic stirrer, adding oleic acid, stirring evenly, adding methanol, stirring evenly, dropping sodium hydroxide solution, stirring evenly, dropping calcium chloride solution, stirring evenly, and then dropping sodium dihydrogen phosphate dihydrate solution, heating and then cooling to room temperature, separating to obtain a light yellow viscous liquid on the upper layer and a hydroxyapatite nanowire solution on the lower layer; (2) preheating the hydroxyapatite nanowire solution and the light yellow viscous liquid prepared in (1) respectively, adding the light yellow viscous liquid into the hydroxyapatite nanowire solution and stirring evenly to obtain solution A; (3) adding bioglass and polymer binder to solution A in sequence to obtain solution B, stirring solution B evenly until it is completely dispersed to obtain a 3D printable viscous slurry C, using the viscous slurry C for 3D printing to obtain product D, allowing product D to stand, cutting the desired length and taking it out, and obtaining flexible hydroxyapatite nanowire bundles after drying; (4) adding bioglass and polymer binder to solution A in sequence to obtain solution E, stirring solution E evenly until completely dispersed to obtain 3D printable viscous slurry F, using fibers and viscous slurry F for 3D printing to obtain product G, allowing product G to stand and then cutting the desired length and taking it out, and after drying, obtaining continuous fiber flexible hydroxyapatite nanowire bundles; (5) weaving the flexible hydroxyapatite nanowire bundles obtained in (3), or weaving the continuous fiber flexible hydroxyapatite nanowire bundles obtained in (4), or weaving the flexible hydroxyapatite nanowire bundles obtained in (3) and the continuous fiber flexible hydroxyapatite nanowire bundles obtained in (4) together to obtain a hydroxyapatite nanowire ceramic bone bandage; Further, the (1) is specifically as follows: deionized water, oleic acid and methanol are weighed respectively according to the volume ratio of (15 to 20): (10 to 20): (5 to 10), the deionized water is magnetically stirred at a speed of 400 to 1500 r / min, oleic acid is added, and methanol is added after stirring evenly, and then a sodium hydroxide solution with a concentration of 0.05 to 0.2 g / ml is dripped and stirred evenly for 30 min, a calcium chloride solution with a concentration of 0.01 to 0.05 g / ml is dripped and stirred evenly for 30 min, and then a sodium dihydrogen phosphate dihydrate solution with a concentration of 0.05 to 0.1 g / ml is dripped and stirred evenly until it becomes white and viscous, wherein the volume ratios of deionized water, oleic acid, methanol, sodium hydroxide solution, calcium chloride solution and sodium dihydrogen phosphate dihydrate solution are (15 to 20): (10 to 20): (5 to 10): (15 to 25): (15 to 25): (15 to 25) 25), then heated at 170-200 °C for 20-30 h and cooled to room temperature to separate the upper light yellow viscous liquid and the lower hydroxyapatite nanowire solution; Furthermore, the diameter of the hydroxyapatite nanowires in the hydroxyapatite nanowire solution obtained in (1) is 20-100 nm, and the length is 100-600 μm; Furthermore, the preheating temperature in (2) is 50-90°C, and the time is 10-90 min; the mass ratio of the light yellow viscous liquid to the hydroxyapatite nanowire solution in the solution A is 1:(1-6); Furthermore, the mass ratio of the hydroxyapatite nanowire solution, the bioglass and the polymer binder in the solution B of (3) is (75-95): (0-10): (5-15); Furthermore, the 3D printing using the viscous slurry C in (3) is specifically as follows: using a printing device to squeeze the viscous slurry C into ethanol; the standing time is 10 to 90 minutes; Furthermore, the mass ratio of the hydroxyapatite nanowire solution, the bioglass and the polymer binder in the solution E of (4) is (74-96.99): (0-10): (3-15); Furthermore, the use of fibers and viscous slurry F for 3D printing in (4) is specifically as follows: weigh the fibers according to a proportion, divide the fibers evenly into the required number of portions to obtain a fiber bundle, take one portion of the fibers and fix them on a fine needle, pass the fibers through the printing device together with the fine needle, then remove the fine needle, squeeze the viscous slurry F and the fibers into ethanol together, after one portion of the fibers is extruded, use the fine needle to penetrate another portion of the fibers, squeeze the viscous slurry F and the fibers into ethanol together again, and repeat until the viscous slurry F is used up; the standing time is 10 to 90 minutes; Furthermore, the fibers are weighed according to the mass ratio of hydroxyapatite nanowire solution, bioglass, polymer binder and fiber of (74-96.99): (0-10): (3-15): (0.01-1); the diameter of the fiber bundle is 5-300 um.
[0007] A hydroxyapatite nanowire ceramic bone bandage is obtained based on the above-mentioned preparation method of the hydroxyapatite nanowire ceramic bone bandage.
[0008] The above technical solution has the following advantages or beneficial effects: The present invention provides a method for preparing a hydroxyapatite nanowire ceramic bone bandage. The entire preparation process is relatively simple, environmentally friendly, and easy to realize industrial production. Through the steps of preheating, stirring, 3D printing, weaving, etc., high-quality hydroxyapatite nanowire ceramic bone bandage can be efficiently prepared. Hydroxyapatite is the main inorganic component of human bones and teeth, and has good biocompatibility and bone conduction. The hydroxyapatite prepared in the form of nanowires not only retains these excellent biological properties, but also has a higher specific surface area and better mechanical properties due to its nanostructure, such as higher strength and toughness, so that the prepared bone bandage has significant advantages in promoting bone tissue regeneration and repair. The prepared hydroxyapatite nanowire solution is mixed with light yellow The combination of colored viscous liquid, bioglass and polymer binder provides a good material basis for subsequent 3D printing and weaving processes; the preparation method of the present invention utilizes 3D printing technology to prepare bone bandages, which can achieve precise control of the shape, size and structure of the bandage to meet the bone repair needs of different parts and different degrees of injury. This personalized customization capability greatly improves the treatment effect and patient comfort; the flexible hydroxyapatite nanowire bundles or continuous fiber flexible hydroxyapatite nanowire bundles are combined into a bone bandage through a weaving process, which not only improves the overall strength and toughness of the bandage, but also increases its air permeability and comfort. The weaving process also allows the structure and density of the bandage to be adjusted according to specific needs to adapt to different treatment scenarios, and has strong process flexibility.
[0009] Furthermore, by precisely controlling the raw material ratio and reaction conditions (such as stirring speed, heating temperature and time), hydroxyapatite nanowires with high purity, uniform particle size and single morphology can be prepared. These nanowires have excellent biocompatibility and osteoconductivity, providing a good foundation for subsequent bone tissue repair. The process of preparing hydroxyapatite nanowire solution is carried out under relatively mild conditions, and by precisely controlling the operating parameters of each step, effective regulation of the reaction process can be achieved, thereby improving the quality and yield of the product.
[0010] Furthermore, the diameter of the hydroxyapatite nanowires is 20~100 nm. This size range makes the nanowires have significant nano effects, such as high specific surface area, high surface activity, etc., which is conducive to the interaction between the nanowires and biological tissues, and promotes the regeneration and repair of bone tissue; the length of the hydroxyapatite nanowires is 100~600 μm. This size range makes the nanowires have a certain flexibility, so that the nanowires can form a stable network structure when woven into a bone bandage, thereby improving the overall mechanical strength and toughness of the bandage.
[0011] Furthermore, by preheating, it can be ensured that the hydroxyapatite nanowire solution and the light yellow viscous liquid reach similar temperatures before mixing, reducing local coagulation or agglomeration caused by temperature difference, thereby improving the uniformity and efficiency of mixing.
[0012] Furthermore, by adjusting the ratio of each component, the content of each component in the composite material can be precisely controlled, thereby optimizing the mechanical properties, biocompatibility and processing properties of the composite material.
[0013] Furthermore, after the viscous slurry is squeezed into ethanol, the water, oleic acid and other solvents in the slurry can quickly dissolve into the ethanol, allowing the nanowires to quickly adsorb and bridge each other, thereby forming a strong, tough hydroxyapatite nanowire bundle, improving production efficiency; 3D printing can accurately control the extrusion amount and position of the viscous slurry, thereby achieving high-precision, uniform-diameter hydroxyapatite nanowire bundle molding, which is crucial for the preparation of bone bandages with specific shapes and sizes, and can ensure that the bandage fits tightly to the bone defect site; by standing for a period of time (10 to 90 minutes), the cured structure can be further stabilized, reducing internal stress and defects, which helps to improve the mechanical properties and durability of the bone bandage, and ensure that it can maintain a stable structure and function for a long time in the in vivo environment.
[0014] Furthermore, the fiber plays a role of a skeleton in the composite material, significantly improving the mechanical strength, toughness and fatigue resistance of the bone bandage. The composite material formed by the fiber, hydroxyapatite nanowires, bioglass and polymer binder can more effectively disperse and withstand stress, enhance the stability and integrity of the structure, and reduce the risk of fracture and failure. Even when subjected to external impact or deformation, the fiber can maintain a certain shape and position, preventing serious damage or deformation of the composite material.
[0015] Furthermore, by adjusting parameters such as fiber diameter, length and distribution, the mechanical properties and structural characteristics of the bone bandage can be further optimized. At the same time, combined with the high flexibility and customizability of 3D printing technology, bone bandages with complex shapes and structures can be prepared to meet the treatment needs of different patients.
[0016] The present invention provides a hydroxyapatite nanowire ceramic bone bandage. Firstly, it can avoid complications caused by the implant site due to the mismatch between the mechanical properties of the implant and the properties of the artificial bone. Secondly, the bone bandage is made of hydroxyapatite material, which can fully provide Ca and P sources to promote the growth of bone cells, enhance the natural healing ability, accelerate fracture healing, promote bone cell growth, provide support for bone cells like a scaffold, and repair the fracture site faster. This natural healing method is more efficient than traditional treatment methods. In addition, since the bone bandage is made of biocompatible material, it can reduce the risk of wound infection. After the fracture is healed, the bandage will harmlessly dissolve and be absorbed by the body, avoiding secondary trauma caused by secondary surgery to remove it. Finally, it is convenient for doctors to perform surgical operations, can lower the technical threshold of doctors, and is convenient for widespread use and rapid promotion. BRIEF DESCRIPTION OF THE DRAWINGS
[0017] Figure 1 Schematic diagram of the preparation process of hydroxyapatite nanowire ceramic bone bandage; in the figure, (a) is a schematic diagram of the preparation of hydroxyapatite nanowire bundles; (b) is a schematic diagram of the drying of hydroxyapatite nanowire bundles; (c) is a schematic diagram of the weaving of the bone bandage; Figure 2 The SEM images of the microstructure of hydroxyapatite nanowires; in the figure, (a) is the SEM image of the microstructure of 5 um hydroxyapatite nanowires; (b) is the SEM image of the microstructure of 1 um hydroxyapatite nanowires; Figure 3 This is the SEM image of hydroxyapatite nanowire bundles doped with bioglass; Figure 4 Schematic diagram of 3D printing using fibers and viscous slurry; Figure 5 Schematic diagrams of hydroxyapatite nanowire ceramic bone bandages prepared in Example 1 and Example 2; in the figure, (a) is a schematic diagram of the hydroxyapatite nanowire ceramic bone bandage of Example 1; (b) is a schematic diagram of the hydroxyapatite nanowire ceramic bone bandage of Example 2; Figure 6 A schematic diagram of the flexibility of the hydroxyapatite nanowire ceramic bone bandage prepared in Example 1; Figure 7 Schematic diagram of the application of the hydroxyapatite nanowire ceramic bone bandage prepared in Example 2; in the figure, (a) is a schematic diagram of the ceramic bone bandage without the use of hydroxyapatite nanowires; (b) is a schematic diagram of the ceramic bone bandage with the use of hydroxyapatite nanowires; Figure 8 Schematic diagram of the mechanical properties of the hydroxyapatite nanowire ceramic bone bandage prepared in Example 2. DETAILED DESCRIPTION
[0018] The present invention is further described in detail below in conjunction with specific embodiments, which are intended to explain the present invention rather than to limit it.
[0019] In order to enable those skilled in the art to better understand the scheme of the present invention, the technical scheme in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work should fall within the scope of protection of the present invention.
[0020] It should be noted that the terms "first", "second", etc. in the specification and claims of the present invention and the above-mentioned drawings are used to distinguish similar objects, and are not necessarily used to describe a specific order or sequence. It should be understood that the data used in this way can be interchanged where appropriate, so that the embodiments of the present invention described herein can be implemented in an order other than those illustrated or described herein. In addition, the terms "including" and "having" and any variations thereof are intended to cover non-exclusive inclusions, for example, a process, method, system, product or device that includes a series of steps or units is not necessarily limited to those steps or units that are clearly listed, but may include other steps or units that are not clearly listed or inherent to these processes, methods, products or devices.
[0021] A method for preparing a hydroxyapatite nanowire ceramic bone bandage comprises the following steps: (1) Preparation of hydroxyapatite nanowire solution: Deionized water, oleic acid and methanol were weighed according to the volume ratio of (15 ~ 20): (10 ~ 20): (5 ~ 10), and the deionized water was magnetically stirred at a speed of 400 ~ 1500 r / min. Oleic acid was slowly added and stirred evenly. After that, methanol was added and stirred evenly until it turned off-white. Then, a sodium hydroxide solution with a concentration of 0.05 ~ 0.2 g / ml was dripped and stirred evenly for 30 min. A calcium chloride solution with a concentration of 0.01 ~ 0.05 g / ml was slowly dripped and stirred evenly for 30 min. Then, a sodium dihydrogen phosphate dihydrate solution with a concentration of 0.05 ~ 0.1 g / ml was slowly dripped and stirred evenly until it turned white and viscous. Among them, the volume ratios of deionized water, oleic acid, methanol, sodium hydroxide solution, calcium chloride solution and sodium dihydrogen phosphate dihydrate solution were (15 ~ 20): (10 ~ 20): (5 ~ 10): (15 ~ 25): (15 ~ 25): (15 ~ 25), then heated at 170 ~ 200 ° C for 20 ~ 30 h and cooled to room temperature, and separated to obtain an upper light yellow viscous liquid and a lower hydroxyapatite nanowire solution. The diameter of the hydroxyapatite nanowires in the hydroxyapatite nanowire solution is 20 ~ 100 nm, and the length is 100 ~ 600 μm; (2) preheating the hydroxyapatite nanowire solution and the light yellow viscous liquid prepared in (1) at 50-90 °C for 10-90 min respectively, adding the light yellow viscous liquid into the hydroxyapatite nanowire solution and stirring evenly to obtain solution A, wherein the mass ratio of the light yellow viscous liquid to the hydroxyapatite nanowire solution in solution A is 1:(1-6); (3) Adding bioglass and polymer binder to solution A in sequence to obtain solution B, wherein the mass ratio of hydroxyapatite nanowire solution, bioglass and polymer binder in solution B is (75-95): (0-10): (5-15), stirring solution B evenly until it is completely dispersed to obtain a 3D printable viscous slurry C, squeezing the viscous slurry C into ethanol using a printing device to obtain product D, allowing product D to stand for 10-90 min, cutting the desired appropriate length and taking it out, and drying to obtain flexible hydroxyapatite nanowire bundles; (4) Bioglass and polymer binder are sequentially added to solution A to obtain solution E, wherein the mass ratio of hydroxyapatite nanowire solution, bioglass and polymer binder in solution E is (74-96.99): (0-10): (3-15). Solution E is uniformly stirred until completely dispersed to obtain a 3D printable viscous slurry F. The fibers are weighed according to the mass ratio of hydroxyapatite nanowire solution, bioglass, polymer binder and fiber of (74-96.99): (0-10): (3-15): (0.01-1), and the fibers are evenly divided into the required number of portions to obtain fibers with a diameter of 5-300 mm. um fiber bundle, take 1 part of the fiber and fix it on the fine needle, pass the fiber and the fine needle through the printing device, then remove the fine needle, squeeze the viscous slurry F and the fiber into ethanol together, after 1 part of the fiber is extruded, use the fine needle to penetrate 1 part of the fiber again, squeeze the viscous slurry F and the fiber into ethanol together again, repeat until the viscous slurry F is used up, and obtain product G, let product G stand for 10-90 min, then cut the required appropriate length and take it out, and after drying, obtain continuous fiber flexible hydroxyapatite nanowire bundle; (5) weaving the flexible hydroxyapatite nanowire bundles obtained in (3), or weaving the continuous fiber flexible hydroxyapatite nanowire bundles obtained in (4), or weaving the flexible hydroxyapatite nanowire bundles obtained in (3) and the continuous fiber flexible hydroxyapatite nanowire bundles obtained in (4) together to obtain a hydroxyapatite nanowire ceramic bone bandage; Preferably, the polymer binder includes but is not limited to PVA, chitosan, sodium alginate, methyl cellulose and other binders; the fiber includes but is not limited to carbon fiber, PGA fiber; Preferably, the inner diameter of the nozzle includes but is not limited to 1.8 mm, 1.6 mm, 1.3 mm, 1.0 mm, 0.84 mm, 0.64 mm, 0.55 mm, 0.46 mm, 0.39 mm, 0.30 mm, 0.26 mm, 0.23 mm, and 0.21 mm.
[0022] A hydroxyapatite nanowire ceramic bone bandage is obtained based on the above-mentioned preparation method of the hydroxyapatite nanowire ceramic bone bandage.
[0023] The present invention is further described in detail below in conjunction with specific embodiments, which are intended to explain the present invention rather than to limit it.
[0024] Embodiment 1: like Figure 4 and Figure 5 As shown, the present invention provides a method for preparing a hydroxyapatite nanowire ceramic bone bandage, comprising the following steps: (1) Preparation of hydroxyapatite nanowire solution: 54 ml of deionized water, 42 ml of oleic acid and 24 ml of methanol were weighed in a volume ratio of 9:7:4, and the 54 ml of deionized water was magnetically stirred at a speed of 400 r / min. 42 ml of oleic acid was slowly added, and after stirring evenly, 24 ml of methanol was added and stirred evenly until it turned off-white. Then, a sodium hydroxide solution with a concentration of 0.07 g / ml was dripped in and stirred evenly for 30 min. A calcium chloride solution with a concentration of 0.022 g / ml was slowly dripped in and stirred evenly for 30 min. Then, a sodium dihydrogen phosphate dihydrate solution with a concentration of 0.0624 g / ml was slowly dripped in and stirred evenly until it turned white and viscous. The volume ratio of deionized water, oleic acid, methanol, sodium hydroxide solution, calcium chloride solution and sodium dihydrogen phosphate dihydrate solution was 9:7:4:10:10:10. Then, the mixture was poured into three 200 ml autoclaves respectively, and the autoclaves were placed in a drying oven and heated at 180 °C for 26 ℃. h and then cooled to room temperature, and the upper layer of light yellow viscous liquid and the lower layer of hydroxyapatite nanowire solution were separated. The diameter of hydroxyapatite nanowires in the hydroxyapatite nanowire solution was 80-100 nm and the length was 200-250 μm. (2) The hydroxyapatite nanowire solution and the light yellow viscous liquid prepared in (1) were preheated in a vacuum drying oven at 60°C for 30 min, 18.4 g of the hydroxyapatite nanowire solution was taken, the light yellow viscous liquid was added to the hydroxyapatite nanowire solution and stirred evenly to obtain solution A. The mass ratio of the light yellow viscous liquid to the hydroxyapatite nanowire solution in solution A was 1:4; (3) 1 g of bioglass and 3 g of 20% PVA solution were added to solution A in sequence to obtain solution B. The mass ratio of hydroxyapatite nanowire solution, bioglass and polymer binder in solution B was 92:5:15. Solution B was stirred evenly until completely dispersed to obtain a 3D printable viscous slurry C. The viscous slurry C was transferred to a 50 ml barrel and squeezed evenly into ethanol using a nozzle with an inner diameter of 1.6 mm to obtain product D. After product D was allowed to stand for 60 min, it was cut into the required appropriate length, taken out and placed on a Teflon plate (polytetrafluoroethylene plate), and after drying, a flexible hydroxyapatite nanowire bundle was obtained; (4) Weaving the flexible hydroxyapatite nanowire bundles obtained in (3) to obtain a hydroxyapatite nanowire ceramic bone bandage.
[0025] Embodiment 2: like Figure 4 , Figure 6 and Figure 7 As shown, the present invention provides a method for preparing a hydroxyapatite nanowire ceramic bone bandage, comprising the following steps: (1) Preparation of hydroxyapatite nanowire solution: 162 ml of deionized water, 126 ml of oleic acid and 72 ml of methanol were weighed in a volume ratio of 9:7:4, and the 162 ml of deionized water was magnetically stirred at a speed of 750 r / min. 126 ml of oleic acid was slowly added, and after stirring evenly, 72 ml of methanol was added and stirred evenly until it turned off-white. Then, a sodium hydroxide solution with a concentration of 0.07 g / ml was dripped in and stirred evenly for 30 min. A calcium chloride solution with a concentration of 0.022 g / ml was slowly dripped in and stirred evenly for 30 min. Then, a sodium dihydrogen phosphate dihydrate solution with a concentration of 0.0624 g / ml was slowly dripped in and stirred evenly until it turned white and viscous. The volume ratio of deionized water, oleic acid, methanol, sodium hydroxide solution, calcium chloride solution and sodium dihydrogen phosphate dihydrate solution was 9:7:4:10:10:10. Then, the solutions were poured into five 200 ml autoclaves respectively, and the autoclaves were placed in a drying oven at 180 °C. After heating at ℃ for 24 h and cooling to room temperature, the upper layer of light yellow viscous liquid and the lower layer of hydroxyapatite nanowire solution were separated. The diameter of hydroxyapatite nanowires in the hydroxyapatite nanowire solution was 70-90 nm and the length was 150-200 μm. (2) The hydroxyapatite nanowire solution and the light yellow viscous liquid prepared in (1) were preheated in a vacuum drying oven at 70°C for 20 min, 9.15 g of the hydroxyapatite nanowire solution was taken, the light yellow viscous liquid was added to the hydroxyapatite nanowire solution and stirred evenly to obtain solution A. The mass ratio of the light yellow viscous liquid to the hydroxyapatite nanowire solution in solution A was 1:2; (3) 0.5 g of bioglass and 1.5 g of 20% PVA solution were added to solution A in sequence to obtain solution E. The mass ratio of hydroxyapatite nanowire solution, bioglass and polymer binder in solution E was 91.5:5:15. Solution E was stirred evenly until completely dispersed to obtain a 3D printable viscous slurry F. The viscous slurry F was transferred to a 50 ml barrel. 0.05 g of fiber was weighed according to the mass ratio of hydroxyapatite nanowire solution, bioglass, polymer binder and fiber of 91.5:5:15:0.5. The 0.05 g fiber was evenly divided into 50 portions. One portion of the fiber was fixed on a fine needle. The fiber and the fine needle were passed through a nozzle with an inner diameter of 1.6 mm. The fine needle was then removed and the viscous slurry F and the fiber were evenly squeezed into ethanol using a nozzle with an inner diameter of 1.6 mm. After one portion of the fiber was extruded, the fine needle was used to insert another portion of the fiber. The fine needle was used again to insert another portion of the fiber. The viscous slurry F and the fiber are uniformly squeezed into ethanol through a nozzle of mm, and the process is repeated until the viscous slurry F is exhausted to obtain product G. After the product G is allowed to stand for 30 min, a suitable length is cut and placed on a Teflon plate. After drying, a continuous fiber flexible hydroxyapatite nanowire bundle is obtained. (4) Weaving the continuous fiber flexible hydroxyapatite nanowire bundles obtained in (3) to obtain a hydroxyapatite nanowire ceramic bone bandage.
[0026] Embodiment 3: The present invention provides a method for preparing a hydroxyapatite nanowire ceramic bone bandage, comprising the following steps: (1) Preparation of hydroxyapatite nanowire solution: 150 ml of deionized water, 100 ml of oleic acid and 50 ml of methanol were weighed in a volume ratio of 15:10:5, and the 150 ml of deionized water was magnetically stirred at a speed of 1500 r / min. 100 ml of oleic acid was slowly added, and after stirring evenly, 50 ml of methanol was added and stirred evenly until it turned off-white. Then, a sodium hydroxide solution with a concentration of 0.2 g / ml was dripped in and stirred evenly for 30 min. A calcium chloride solution with a concentration of 0.05 g / ml was slowly dripped in and stirred evenly for 30 min. Then, a sodium dihydrogen phosphate dihydrate solution with a concentration of 0.1 g / ml was slowly dripped in and stirred evenly until it turned white and viscous. The volume ratio of deionized water, oleic acid, methanol, sodium hydroxide solution, calcium chloride solution and sodium dihydrogen phosphate dihydrate solution was 15:10:5:15:15:15. Then, the mixture was poured into five 200 ml autoclaves respectively, and the autoclaves were placed in a drying oven at 200 After heating at ℃ for 30 h and cooling to room temperature, the upper layer of light yellow viscous liquid and the lower layer of hydroxyapatite nanowire solution were separated. The diameter of hydroxyapatite nanowires in the hydroxyapatite nanowire solution was 80-100 nm and the length was 400-600 μm. (2) The hydroxyapatite nanowire solution and the light yellow viscous liquid prepared in (1) were preheated in a vacuum drying oven at 90°C for 90 min, 19 g of the hydroxyapatite nanowire solution was taken, the light yellow viscous liquid was added to the hydroxyapatite nanowire solution and stirred evenly to obtain solution A. The mass ratio of the light yellow viscous liquid to the hydroxyapatite nanowire solution in solution A was 1:6; (3) 2 g of bioglass and 3 g of 20% PVA solution were added to solution A in sequence to obtain solution B. The mass ratio of hydroxyapatite nanowire solution, bioglass and polymer binder in solution B was 95:10:15. Solution B was stirred evenly until completely dispersed to obtain a 3D printable viscous slurry C. The viscous slurry C was transferred to a 50 ml barrel and squeezed evenly into ethanol using a nozzle with an inner diameter of 1.8 mm to obtain product D. After product D was allowed to stand for 90 min, it was cut to the required appropriate length, taken out and placed on a Teflon plate. After drying, flexible hydroxyapatite nanowire bundles were obtained. (4) Add 2 g of bioglass and 0.6 g of 20% PVA solution to solution A in sequence to obtain solution E. The mass ratio of hydroxyapatite nanowire solution, bioglass and polymer binder in solution E is 95:10:3. Stir solution E evenly until it is completely dispersed to obtain a 3D printable viscous slurry F. Transfer the viscous slurry F to a 50 ml barrel. According to the mass ratio of hydroxyapatite nanowire solution, bioglass, polymer binder and fiber of 95:10:3:1, weigh 0.2 g of fiber. Divide the 0.2 g of fiber into 50 portions. Fix 1 portion of fiber on a fine needle. Pass the fiber through a nozzle with an inner diameter of 1.8 mm along with the fine needle. Then remove the fine needle and use a nozzle with an inner diameter of 1.8 mm to evenly squeeze the viscous slurry F and the fiber into ethanol. After 1 portion of fiber is extruded, use the fine needle to insert 1 portion of fiber again. Use a nozzle with an inner diameter of 1.8 mm again. The viscous slurry F and the fiber are uniformly squeezed into ethanol through a nozzle of mm, and the process is repeated until the viscous slurry F is exhausted to obtain a product G. The product G is allowed to stand for 90 min, and then cut into the required appropriate length, and then taken out and placed on a Teflon plate, and after drying, a continuous fiber flexible hydroxyapatite nanowire bundle is obtained; (5) Weaving the flexible hydroxyapatite nanowire bundles obtained in (3) and the continuous fiber flexible hydroxyapatite nanowire bundles obtained in (4) together to obtain a hydroxyapatite nanowire ceramic bone bandage.
[0027] Embodiment 4: The present invention provides a method for preparing a hydroxyapatite nanowire ceramic bone bandage, comprising the following steps: (1) Preparation of hydroxyapatite nanowire solution: 20 ml of deionized water, 20 ml of oleic acid and 10 ml of methanol were weighed in a volume ratio of 20:20:10, and 20 ml of deionized water was magnetically stirred at 400 r / min. 20 ml of oleic acid was slowly added, and after stirring evenly, 10 ml of methanol was added and stirred evenly until it turned off-white. Then, 0.05 g / ml of sodium hydroxide solution was dripped in and stirred evenly for 30 min. 0.01 g / ml of calcium chloride solution was slowly dripped in and stirred evenly for 30 min. Then, 0.05 g / ml of sodium dihydrogen phosphate dihydrate solution was slowly dripped in and stirred evenly until it turned white and viscous. The volume ratio of deionized water, oleic acid, methanol, sodium hydroxide solution, calcium chloride solution and sodium dihydrogen phosphate dihydrate solution was 20:20:10:25:25:25. Then, the solutions were poured into two 200 ml autoclaves respectively, and the autoclaves were placed in a drying oven and heated at 170 °C for 20 min. h and then cooled to room temperature, and the upper layer of light yellow viscous liquid and the lower layer of hydroxyapatite nanowire solution were separated. The diameter of hydroxyapatite nanowires in the hydroxyapatite nanowire solution was 20-60 nm and the length was 100-300 μm. (2) The hydroxyapatite nanowire solution and the light yellow viscous liquid prepared in (1) were preheated in a vacuum drying oven at 50°C for 10 min, respectively. 7.4 g of the hydroxyapatite nanowire solution was taken, and the light yellow viscous liquid was added to the hydroxyapatite nanowire solution and stirred evenly to obtain solution A. The mass ratio of the light yellow viscous liquid to the hydroxyapatite nanowire solution in solution A was 1:1. (3) 0.3 g of 20% PVA solution was added to solution A in sequence to obtain solution E. The mass ratio of hydroxyapatite nanowire solution, bioglass and polymer binder in solution E was 74:0:3. Solution E was stirred evenly until completely dispersed to obtain a 3D printable viscous slurry F. The viscous slurry F was transferred to a 50 ml barrel. 0.001 g of fiber was weighed according to the mass ratio of hydroxyapatite nanowire solution, bioglass, polymer binder and fiber of 74:0:3:0.01. 0.001 g of fiber was evenly divided into 50 portions. One portion of fiber was fixed on a fine needle. The fiber and the fine needle were passed through a nozzle with an inner diameter of 1 mm. The fine needle was then removed and the viscous slurry F and the fiber were evenly squeezed into ethanol using a nozzle with an inner diameter of 1 mm. After one portion of fiber was extruded, the fine needle was used to insert another portion of fiber. The fine needle was used again to insert another portion of fiber. The viscous slurry F and the fiber are uniformly squeezed into ethanol through a nozzle of mm, and the process is repeated until the viscous slurry F is exhausted to obtain a product G. The product G is allowed to stand for 10 min, and then cut into the required appropriate length, and then taken out and placed on a Teflon plate, and after drying, a continuous fiber flexible hydroxyapatite nanowire bundle is obtained; (4) Weaving the continuous fiber flexible hydroxyapatite nanowire bundles obtained in (3) to obtain a hydroxyapatite nanowire ceramic bone bandage.
[0028] Embodiment 5: The present invention provides a method for preparing a hydroxyapatite nanowire ceramic bone bandage, comprising the following steps: (1) Preparation of hydroxyapatite nanowire solution: 162 ml of deionized water, 126 ml of oleic acid and 72 ml of methanol were weighed in a volume ratio of 9:7:4, and 162 ml of deionized water was magnetically stirred at 750 r / min. 126 ml of oleic acid was slowly added and stirred evenly. After that, 72 ml of methanol was added and stirred evenly until it turned off-white. Then, 0.07 g / ml of sodium hydroxide solution was dripped into it and stirred evenly for 30 min. 0.022 g / ml of calcium chloride solution was slowly dripped into it and stirred evenly for 30 min. Then, 0.0624 g / ml of sodium dihydrogen phosphate dihydrate solution was slowly dripped into it and stirred evenly until it turned white and viscous. The solutions were poured into five 200 ml autoclaves respectively, and the autoclaves were placed in a drying oven and heated at 180 °C for 24 hr. h and then cooled to room temperature, and the upper layer of light yellow viscous liquid and the lower layer of hydroxyapatite nanowire solution were separated. The diameter of hydroxyapatite nanowires in the hydroxyapatite nanowire solution was 70-90 nm and the length was 150-200 μm. (2) The hydroxyapatite nanowire solution and the light yellow viscous liquid prepared in (1) were preheated in a vacuum drying oven at 70°C for 20 min, 9.699 g of the hydroxyapatite nanowire solution was taken, the light yellow viscous liquid was added to the hydroxyapatite nanowire solution and stirred evenly to obtain solution A. The mass ratio of the light yellow viscous liquid to the hydroxyapatite nanowire solution in solution A was 1:2. (3) 0.5 g of bioglass and 1.5 g of 20% PVA solution were added to solution A in sequence to obtain solution E. The mass ratio of hydroxyapatite nanowire solution, bioglass and polymer binder in solution E was 96.99:5:15. Solution E was stirred evenly until completely dispersed to obtain a 3D printable viscous slurry F. The viscous slurry F was transferred to a 50 ml barrel. 0.05 g of fiber was weighed according to the mass ratio of hydroxyapatite nanowire solution, bioglass, polymer binder and fiber of 96.99:5:15:0.5. The 0.05 g fiber was evenly divided into 50 portions. One portion of the fiber was fixed on a fine needle. The fiber and the fine needle were passed through a nozzle with an inner diameter of 1.6 mm. The fine needle was then removed and the viscous slurry F and the fiber were evenly squeezed into ethanol using a nozzle with an inner diameter of 1.6 mm. After one portion of the fiber was extruded, the fine needle was used to insert another portion of the fiber. The fine needle was used again to insert another portion of the fiber. The viscous slurry F and the fiber are uniformly squeezed into ethanol through a nozzle of mm, and the process is repeated until the viscous slurry F is exhausted to obtain product G. After the product G is allowed to stand for 30 min, a suitable length is cut and placed on a Teflon plate. After drying, a continuous fiber flexible hydroxyapatite nanowire bundle is obtained. (4) Weaving the continuous fiber flexible hydroxyapatite nanowire bundles obtained in (3) to obtain a hydroxyapatite nanowire ceramic bone bandage.
[0029] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or replace some or all of the technical features therein with equivalents. However, these modifications or replacements do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present invention.
Claims
1. A method for preparing a hydroxyapatite nanowire ceramic bone bandage, characterized in that: The steps include: S1, magnetically stirring deionized water, adding oleic acid, stirring evenly, adding methanol, stirring evenly, dropping sodium hydroxide solution, stirring evenly, dropping calcium chloride solution, stirring evenly, and then dropping sodium dihydrogen phosphate dihydrate solution, heating and then cooling to room temperature, separating to obtain a light yellow viscous liquid on the upper layer and a hydroxyapatite nanowire solution on the lower layer; S2, preheating the hydroxyapatite nanowire solution and the light yellow viscous liquid prepared in S1 respectively, adding the light yellow viscous liquid into the hydroxyapatite nanowire solution and stirring evenly to obtain solution A; S3, adding bioglass and polymer binder to solution A in sequence to obtain solution B, stirring solution B evenly until it is completely dispersed to obtain 3D printable viscous slurry C, using viscous slurry C for 3D printing to obtain product D, leaving product D to stand, cutting a desired length and taking it out, and obtaining flexible hydroxyapatite nanowire bundles after drying; S4, adding bioglass and polymer binder to solution A in sequence to obtain solution E, stirring solution E evenly until completely dispersed to obtain 3D printable viscous slurry F, using fibers and viscous slurry F for 3D printing to obtain product G, leaving product G to stand, cutting a desired length and taking it out, and obtaining continuous fiber flexible hydroxyapatite nanowire bundles after drying; S5, weaving the flexible hydroxyapatite nanowire bundles obtained in S3, or weaving the continuous fiber flexible hydroxyapatite nanowire bundles obtained in S4, or weaving the flexible hydroxyapatite nanowire bundles obtained in S3 and the continuous fiber flexible hydroxyapatite nanowire bundles obtained in S4 together to obtain a hydroxyapatite nanowire ceramic bone bandage.
2. The method for preparing a hydroxyapatite nanowire ceramic bone bandage according to claim 1, characterized in that: Specifically, S1 comprises: weighing deionized water, oleic acid and methanol according to a volume ratio of (15-20): (10-20): (5-10), magnetically stirring the deionized water at a speed of 400-1500 r / min, adding oleic acid, stirring evenly, adding methanol, stirring evenly, dripping a sodium hydroxide solution with a concentration of 0.05-0.2 g / ml and stirring evenly for 30 min, dripping a calcium chloride solution with a concentration of 0.01-0.05 g / ml and stirring evenly for 30 min, and then dripping a calcium chloride solution with a concentration of 0.05-0.2 g / ml and stirring evenly for 30 min. .05-0.1 g / ml sodium dihydrogen phosphate dihydrate solution is uniformly stirred until it becomes white and viscous, wherein the volume ratio of deionized water, oleic acid, methanol, sodium hydroxide solution, calcium chloride solution and sodium dihydrogen phosphate dihydrate solution is (15-20):(10-20):(5-10):(15-25):(15-25):(15-25), then heated at 170-200° C. for 20-30 h and then cooled to room temperature to separate the upper light yellow viscous liquid and the lower hydroxyapatite nanowire solution.
3. The method for preparing a hydroxyapatite nanowire ceramic bone bandage according to claim 2, characterized in that: The diameter of the hydroxyapatite nanowires in the hydroxyapatite nanowire solution obtained in S1 is 20 to 100 nm, and the length is 100 to 600 μm.
4. The method for preparing a hydroxyapatite nanowire ceramic bone bandage according to claim 1, characterized in that: The preheating temperature in S2 is 50-90° C., and the preheating time is 10-90 min. The mass ratio of the light yellow viscous liquid to the hydroxyapatite nanowire solution in the solution A is 1:(1-6).
5. The method for preparing a hydroxyapatite nanowire ceramic bone bandage according to claim 1, characterized in that: The mass ratio of the hydroxyapatite nanowire solution, the bioglass and the polymer binder in the solution B of S3 is (75-95): (0-10): (5-15).
6. The method for preparing a hydroxyapatite nanowire ceramic bone bandage according to claim 1, characterized in that: The specific method of using the viscous slurry C for 3D printing in S3 is as follows: using a printing device to squeeze the viscous slurry C into ethanol; and the standing time is 10 to 90 minutes.
7. The method for preparing a hydroxyapatite nanowire ceramic bone bandage according to claim 1, characterized in that: The mass ratio of the hydroxyapatite nanowire solution, the bioglass and the polymer binder in the solution E of S4 is (74-96.99): (0-10): (3-15).
8. The method for preparing a hydroxyapatite nanowire ceramic bone bandage according to claim 1, characterized in that: The use of fibers and viscous slurry F for 3D printing in S4 is specifically as follows: weigh the fibers according to a proportion, divide the fibers evenly into the required number of portions to obtain a fiber bundle, fix one portion of the fibers on a fine needle, pass the fibers through the printing device together with the fine needle, then remove the fine needle, squeeze the viscous slurry F and the fibers into ethanol together, after one portion of the fibers is extruded, use the fine needle to penetrate another portion of the fibers, squeeze the viscous slurry F and the fibers into ethanol together again, and repeat until the viscous slurry F is used up; the standing time is 10 to 90 minutes.
9. The method for preparing a hydroxyapatite nanowire ceramic bone bandage according to claim 8, characterized in that: The fibers are weighed according to the mass ratio of hydroxyapatite nanowire solution, bioglass, polymer binder and fiber of (74-96.99): (0-10): (3-15): (0.01-1); the diameter of the fiber bundle is 5-300um.
10. A hydroxyapatite nanowire ceramic bone bandage, characterized in that: The invention is obtained by the preparation method of a hydroxyapatite nanowire ceramic bone bandage according to any one of claims 1 to 9.
